| MSGZX | NRGSX | MSGZX / NRGSX | |
| Total Expense Ratio | 0.85 | 0.74 | 115% |
| Annual Report Gross Expense Ratio | 0.88 | 0.74 | 119% |
| Fund Existence | 16 years | 14 years | - |
| Gain YTD | 18.433 | 11.425 | 161% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 681M | 6.95B | 10% |
| Annual Yield % from dividends | 0.00 | 0.44 | - |
| Returns for 1 year | 5.20 | -8.11 | -64% |
| Returns for 3 years | 32.31 | 2.69 | 1,200% |
| Returns for 5 years | -15.96 | -23.14 | 69% |
| Returns for 10 years | 43.29 | 10.53 | 411% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RYCMX | 54.46 | N/A | N/A |
| Rydex Russell 2000 1.5x Strategy C | |||
| MSIBX | 22.95 | N/A | N/A |
| Morgan Stanley Inst Passport ovrs eq A | |||
| SHISX | 63.45 | N/A | N/A |
| BlackRock Health Sciences Opps Svc | |||
| MAFOX | 8.02 | N/A | N/A |
| BlackRock Large Cap Focus Growth Instl | |||
| WVAIX | 44.16 | N/A | N/A |
| Weitz Large Cap Equity-Institutional Cl | |||